Shigenori Ohkawa - Japan Tobacco Director
| JAPAY Stock | USD 13.49 0.08 0.60% |
Director
Shigenori Ohkawa is Executive Officer, Director of Medicine General Research Institute in Medicine Business Unit of Japan Tobacco ADR since 2014.
| Tenure | 10 years |
| Phone | 81 3 6636 2914 |
| Web | https://www.jt.com |
Japan Tobacco Management Efficiency
The company has return on total asset (ROA) of 0.0589 % which means that it generated a profit of $0.0589 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.12 %, meaning that it generated $0.12 on every $100 dollars invested by stockholders. Japan Tobacco's management efficiency ratios could be used to measure how well Japan Tobacco manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Sue Clark | Imperial Brands PLC | 54 | |
| Jon Stanton | Imperial Brands PLC | 49 | |
| Matthew Phillips | Imperial Brands PLC | 46 | |
| Peggy Hebard | Turning Point Brands | 44 | |
| James Cornell | 22nd Century Group | 57 | |
| Charles Foster | Universal | 71 | |
| Luc Jobin | British American Tobacco | 61 | |
| Chester Crocker | Universal | 72 | |
| Eddie Moore | Universal | 71 | |
| Karen Segundo | British American Tobacco | 68 | |
| Peter Corijn | Imperial Brands PLC | N/A | |
| Malcolm Wyman | Imperial Brands PLC | 70 | |
| Giovanni Giordano | British American Tobacco | 51 | |
| Paul Carlucci | Vector Group | 72 | |
| David Haines | Imperial Brands PLC | N/A | |
| Karen Witts | Imperial Brands PLC | N/A | |
| James Barrett | British American Tobacco | 49 | |
| Robert Sledd | Universal | 67 | |
| Steven Stanbrook | Imperial Brands PLC | 60 | |
| Muneaki Fujimoto | Japan Tobacco | N/A | |
| Arnold Zimmerman | Turning Point Brands | 83 | |
Management Performance
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0589 |
Japan Tobacco ADR Leadership Team
Elected by the shareholders, the Japan Tobacco's board of directors comprises two types of representatives: Japan Tobacco inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Japan. The board's role is to monitor Japan Tobacco's management team and ensure that shareholders' interests are well served. Japan Tobacco's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Japan Tobacco's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yasushi Shingai, Vice President Executive Officer, Representative Director | ||
| Hideki Miyazaki, Vice President Executive Officer, Director | ||
| Koichi Mori, Executive Officer | ||
| Hiroyuki Ikuma, Executive Officer | ||
| Masahiko Sato, Executive Officer, Senior Director of Manufacturing in Main Tobacco Business Unit | ||
| Atsuhiro Kawamata, Executive Officer | ||
| Eiichi Kiyokawa, Managing Executive Officer | ||
| Haruhiko Yamada, Chief Legal Officer and Sr. VP | ||
| Yukiko Nagashima, Independent Director | ||
| Yuki Maeda, Chief Communications Officer and Sr. VP | ||
| Takanori Kikuchi, Executive Officer | ||
| Koichiro Watanabe, Independent Director | ||
| Yasushi Hasegawa, Executive Officer, Senior Director of Material in Main Tobacco Business Unit | ||
| Chigusa Ogawa, Executive Officer | ||
| Kenji Ogura, Executive Officer | ||
| Noriaki Ohkubo, Vice President Executive Officer, Representative Director | ||
| Ryoko Nagata, Executive Officer, Chief CSR Officer | ||
| Hiroyuki Miki, Executive Officer | ||
| Akihiro Koyanagi, Executive Officer | ||
| Mutsuo Iwai, Senior Managing Executive Officer | ||
| Main Koda, Independent Director | ||
| Yasuhiro Nakajima, Executive Officer | ||
| Shiroji Maeda, Managing Executive Officer | ||
| Motoyuki Oka, Independent Director | ||
| Ryoji Chijiiwa, Sr. VP of Compliance and General Affairs | ||
| Shuichi Hirosue, Executive Officer | ||
| Mitsuomi Koizumi, CEO and President Representative Director and Member of Executive Committee | ||
| Takehiko Tsutsui, Executive Officer | ||
| Takehisa Shibayama, Executive Officer | ||
| Kiyohide Hirowatari, Chief Legal Officer and Sr. VP | ||
| Main Kohda, Independent Director | ||
| Shigenori Ohkawa, Executive Officer, Director of Medicine General Research Institute in Medicine Business Unit | ||
| Muneaki Fujimoto, Executive Officer, Director of Medicine Business | ||
| Junichi Fukuchi, Executive Officer, Manager of Business Planning Office in Main Tobacco Business Unit | ||
| Goichi Matsuda, Executive Officer, Director of Beverage Business | ||
| Dinesh Thotakura, Gen Division | ||
| Kazuhito Yamashita, Executive Officer | ||
| Akira Saeki, Vice President Executive Officer, Chief Director of Tobacco Business, Representative Director | ||
| Kei Nakano, Executive Officer | ||
| Masamichi Terabatake, President Executive President CEO, Representative Director | ||
| Nobuya Kato, VP CFO | ||
| Toru Oguchi, Executive Officer, Director of China Business in Main Tobacco Business Unit | ||
| Hirakazu Ohtomo, Executive Officer | ||
| Chito Sasaki, Chief Human Resource Officer, Executive Officer | ||
| Naohiro Minami, CFO and Sr. VP | ||
| Koji Shimayoshi, Executive Officer | ||
| Osamu Hirose, Sr Counsel | ||
| Yasutake Tango, Chairman of the Board |
Japan Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Japan Tobacco a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0589 | |||
| Profit Margin | 0.16 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 37.17 B | |||
| Shares Outstanding | 3.55 B | |||
| Price To Earning | 11.74 X | |||
| Price To Book | 1.33 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 2.32 T |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Japan Tobacco in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Japan Tobacco's short interest history, or implied volatility extrapolated from Japan Tobacco options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Japan Tobacco ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Japan Tobacco ADR information on this page should be used as a complementary analysis to other Japan Tobacco's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for Japan Pink Sheet analysis
When running Japan Tobacco's price analysis, check to measure Japan Tobacco's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Japan Tobacco is operating at the current time. Most of Japan Tobacco's value examination focuses on studying past and present price action to predict the probability of Japan Tobacco's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Japan Tobacco's price. Additionally, you may evaluate how the addition of Japan Tobacco to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |